ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX
Delisted
ORTX was delisted on the 23rd of January, 2024.
61 hedge funds and large institutions have $38.9M invested in Orchard Therapeutics plc American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
61
Holding in Top 10
–
Calls
$11K
Puts
–
Top Buyers
| 1 | +$287K | |
| 2 | +$88.6K | |
| 3 | +$38.5K | |
| 4 |
FA
Forefront Analytics
West Conshohocken,
Pennsylvania
|
+$34.1K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$25.2K |
Top Sellers
| 1 | -$3.19M | |
| 2 | -$1.76M | |
| 3 | -$813K | |
| 4 |
Two Sigma Investments
New York
|
-$716K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$477K |